After 34 years in clinical practice, Dr. Evelyn Higgins has brought together her international speaking experience, Diplomate in American College of Addictionology and Compulsive Disorders, along with her Harvard Post-Graduate Body, Mind, Spirit, and Resiliency to work with addiction professionals, mental health practitioners, and American legal societies to better inform documentable and quantifiable evidence of addiction.
Outside of the addiction field, Dr. Higgins was selected as a "Community Hero," and bestowed the privilege of being an Olympic flame torchbearer. She served as the official team doctor for the 1996 Somali Olympic team and the 1993-94 U.S./Ukrainian team for the Whitbread Round the World Race. Honored as one of only 20 broadcasters to participate in the 2013 and 2014 United Nations Radio Talk Day, Dr. Higgins interviewed global goodwill ambassadors such as actor Ed Norton, Stevie Wonder, the director of WHO, UN Women, and others. Dr. Higgins has had the honor of advising the United States Surgeon General on Physical Activity & Women’s Health. Later, she was the Regional Advisor on Economic, Social, and Political Issues to the Government of South Africa for the 2004 Olympic Bid. She was the Physician Delegate for the Somali Olympic Team at the Leroy Walker Huna Performance Center at East Carolina University, and founded the President’ Council Physical Fitness and Sports, Local Georgia Chapter. Dr. Higgins has served as Executive Director of MMUUSA, a global NGO originally based in Tanzania, Africa in addition to the Jupiter Medical Center Women’s Health Advisory Council (Florida, United States of America), and as a Board Member of Veterans Resource Services (Tennessee, United States of America).
Abstract
Wired For Addiction
Wired For Addiction™ is a DNA company that uses our trademark process to look at genetic variants linked to addiction. The scientific community’s understanding of addiction has advanced significantly over the last 30 years largely due to major progress in genetics and neuroscience research. Through the use of Single Nucleotide Polymorphisms, we are able to test if an individual is genetically predisposed for addiction, be it alcohol, drug, sex, or gambling, and if their neurotransmitters and hormones support a dual diagnosis.
No longer are practitioners required to diagnosis and treat based on vocabulary; rather, DNA testing allows one to treat through personalized medicine in order to address the foundational aspects of addiction.